Ignite Creation Date:
2025-12-24 @ 7:15 PM
Ignite Modification Date:
2026-02-20 @ 4:45 PM
Study NCT ID:
NCT00569803
Status:
COMPLETED
Last Update Posted:
2016-09-22
First Post:
2007-11-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Subcutaneous Pharmacokinetics of Belatacept
Sponsor:
Bristol-Myers Squibb
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IM103-046
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None